Clinical trial
Effects of Dynorphin 1-13 on Heroin Addiction - 1
NCT00000244 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00000244 |
|---|---|
| Title | Effects of Dynorphin 1-13 on Heroin Addiction - 1 |
| Official title | Effects of Dynorphin 1-13 on Heroin Addiction |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders, Substance Withdrawal Syndrome |
| Intervention type | Drug |
| Interventions | Dynorphin 1 - 13 |
| Enrollment | 0 |
| Start date | Aug 1, 1994 |
| Primary completion | Mar 1, 1997 |
| Completion | Mar 1, 1997 |
| First posted | Sep 21, 1999 |
| Last update posted | May 27, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: